000250.KQ
Sam Chun Dang Pharm. Co., Ltd$253,500.00
-3.06%Jun 19, 2026
Market cap
$5.35T
52w range
—
P / E
—
EPS · FY 2025
$226.24
Volume
—
Revenue · FY 2025
$231.79B
+9.89% YoY
Explain this page
Arphra AIPlain-English read on Sam Chun Dang Pharm. Co., Ltd’s valuationAI Issuer Brief
Arphra AILoading cached brief…
Fair value
Football field →Weighted blend
$3,708.03
— vs spot
Recommendation
n/a
4 of 4 methods
Method spread
0bull0bear
±5% threshold
Candlestick · 1Y
Open in chart workstation →000250.KQ
253,500+52.16%H 1,233,000L 140,000MA50 382,910MA200 375,089Avg vol 278K
Insider · 30d
History →Bought
$0
0 txns
Sold
$0
0 txns
Net flow
+$0
Recent quarters
All financials →| Period | Revenue | Net income | EPS |
|---|---|---|---|
| Q1 Mar 2026 | $64.87B | $5.45B | $233.15 |
| Q4 Dec 2025 | $66.25B | $5.55B | $238.49 |
| Q3 Sep 2025 | $58.02B | $2.57B | $111.00 |
| Q2 Jun 2025 | $56.9B | -$3.34B | $-143.44 |
| Q1 Mar 2025 | $50.62B | $478.23M | $20.56 |
| Q4 Dec 2024 | $55.19B | -$11.12B | $-480.25 |
Sector & industry today
LiveSectors
- Consumer Cyclical+1.34%
- Technology+0.81%
- Financial Services+0.67%
- Basic Materials+0.44%
- Utilities+0.40%
- Consumer Defensive+0.29%
- Industrials+0.20%
- Communication Services-0.27%
- Energy-0.39%
- Real Estate-0.78%
- Healthcare-0.96%
Top industries (issuer's industry highlighted)
- Biotechnology+6.98%
- Financial - Mortgages+5.74%
- Business Equipment & Supplies+4.80%
- Electronic Gaming & Multimedia+3.88%
- Furnishings, Fixtures & Appliances+3.62%
- Real Estate - Development+3.34%
- Banks+3.32%
- REIT - Industrial-3.09%
- Paper, Lumber & Forest Products+3.02%
- Auto - Recreational Vehicles+2.94%
- Home Improvement+2.94%
- REIT - Specialty-2.89%
Analyst view
Consensus target
—
No price-target data returned for this ticker.
Recent actions
0 ↑0 ↓0 hold
- No recent grade actions.
News
DB · news_itemsNo recent news for 000250.KQ.
Peers
No peer list available for 000250.KQ.
Total assets
$561.23B
Total debt
$69.83B
Cash & equiv
$95.94B
Operating CF
$9.79B
Free cash flow
-$36.35B
Buybacks
$0
Recent insiders
All →| Insider | Action | Shares | Value | Date |
|---|---|---|---|---|
| No open-market insider activity in the recent window. | ||||
Income statement · annual
5y| Period | Revenue | Op income | Net income | EPS | Net margin |
|---|---|---|---|---|---|
| FY 2025 | $231.79B | $8.33B | $5.26B | $226.24 | +2.27% |
| FY 2024 | $210.92B | $2.64B | -$10.92B | $-474.29 | -5.18% |
| FY 2023 | $192.67B | $9.56B | -$10.38B | $-456.23 | -5.39% |
| FY 2022 | $177.34B | $12.57B | $5.84B | $264.52 | +3.29% |
| FY 2021 | $167.27B | -$15.29B | -$16.56B | $-750.19 | -9.90% |